Addenbrooke’s Hospital in Cambridge, United Kingdom, is an internationally known university teaching hospital, serving the local Cambridge area and as a regional and national tertiary referral center for cancer, in particular prostate cancer. The hospital’s oncology and urology departments are one of the leading cancer care specialist services in the UK, seeing several thousand new adult patients a year. In collaboration with the University of Cambridge and Cancer Research UK, The Cambridge Cancer Trials Center (CCTC) brings together high quality clinical care and treatment, underpinned by world-class research.
Addenbrooke’s uses brachytherapy in treating prostate cancer, providing all treatment modalities (RARP, external beam, LDR Brachytherapy and ADT). The hospital treats around 100 patients a year with LDR brachytherapy and the numbers are rising due to the expertise provided. The Brachytherapy Team comprises two oncologists, Dr Russell and Prof Thomas, two Urologists, Mr Kastner and Mr Doble, and eight physicists. The clinicians combine experience and expertise in advanced prostate diagnostics, radiation therapy and technical and technological skill gathered over a number of years and in world leading centres. The facilities including theatres are newly build, patient friendly and spacious.
Addenbrooke’s Hospital is a designated Training Center for brachytherapy. Training visits to the hospital are organized for people wishing to learn more about LDR brachytherapy for prostate cancer, where they can observe clinical workflows and daily practices at first hand.